These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control. Barnas U; Schmidt A; Illievich A; Kiener HP; Rabensteiner D; Kaider A; Prager R; Abrahamian H; Irsigler K; Mayer G Diabetologia; 1997 Mar; 40(3):327-31. PubMed ID: 9084972 [TBL] [Abstract][Full Text] [Related]
27. Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion. Trevisan R; Fioretto P; Semplicini A; Opocher G; Mantero F; Rocco S; Remuzzi G; Morocutti A; Zanette G; Donadon V Diabetes; 1990 Mar; 39(3):289-98. PubMed ID: 2137801 [TBL] [Abstract][Full Text] [Related]
28. The role of hypertension in the development of nephropathy in type 1 (insulin-dependent) diabetes mellitus. Feldt-Rasmussen B; Nørgaard K; Jensen T; Mathiesen E; Deckert T Acta Diabetol Lat; 1990; 27(2):173-9. PubMed ID: 2198748 [TBL] [Abstract][Full Text] [Related]
29. Predisposition to essential hypertension and the development of diabetic nephropathy. Viberti GC; Earle K J Am Soc Nephrol; 1992 Oct; 3(4 Suppl):S27-33. PubMed ID: 1457758 [TBL] [Abstract][Full Text] [Related]
30. Genetic predisposition to hypertension (as detected by Na+/Li+ countertransport) and risk of diabetic nephropathy in childhood diabetes. Chiarelli F; Verrotti A; Kalter-Leibovici O; Laron Z; Morgese G J Paediatr Child Health; 1994 Dec; 30(6):547-9. PubMed ID: 7865273 [TBL] [Abstract][Full Text] [Related]
31. Sodium-hydrogen antiporter: its possible role in the genesis of diabetic nephropathy. Trevisan R; Viberti G Nephrol Dial Transplant; 1997 Apr; 12(4):643-5. PubMed ID: 9140984 [TBL] [Abstract][Full Text] [Related]
32. The progression of diabetic nephropathy in type I diabetics: relationship to metabolic control and blood pressure. Zander E; Schulz B; Mester J; Jutzi E; Templin R; Conde N J Diabet Complications; 1987; 1(2):53-7. PubMed ID: 2969902 [TBL] [Abstract][Full Text] [Related]
33. Predicting renal disease in type I diabetics: smoke and fire or smoke and mirrors? Lenhard MJ Del Med J; 1995 Jul; 67(7):378-87. PubMed ID: 7656999 [TBL] [Abstract][Full Text] [Related]
35. Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. Mangili R; Bending JJ; Scott G; Li LK; Gupta A; Viberti G N Engl J Med; 1988 Jan; 318(3):146-50. PubMed ID: 3336402 [TBL] [Abstract][Full Text] [Related]
36. Hypertension and renal complications in type 2 diabetes. Nosadini R Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601 [TBL] [Abstract][Full Text] [Related]
37. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus]. Lehmann R; Spinas GA Praxis (Bern 1994); 1995 Oct; 84(44):1265-71. PubMed ID: 7491450 [TBL] [Abstract][Full Text] [Related]
39. [Activity of sodium-lithium cotransport in erythrocytes of patients with diabetes mellitus type I (IDDM) complicated by diabetic nephropathy in the renal failure stage]. Trelewicz P; Gumprecht J; Zukowska-Szczechowska E; Grzeszczak W; Moczulski D; Liszka M Pol Arch Med Wewn; 1997 Jun; 97(6):527-33. PubMed ID: 9441288 [TBL] [Abstract][Full Text] [Related]
40. Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria. Chiarelli F; Catino M; Tumini S; de Martino M; Mezzetti A; Verrotti A; Vanelli M Diabetes Care; 1999 Jul; 22(7):1158-64. PubMed ID: 10388982 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]